Biodesix is a data-driven diagnostic solutions company that provides lung cancer diagnostic testing and biopharma services. The company provides physicians with diagnostic tests for earlier disease detection, more accurate diagnosis, disease monitoring, and better therapeutic guidance, which may lead to improved patient outcomes. Biodesix discovers, develops, and commercializes multivariate protein diagnostics based on its proprietary mass spectrometry-based discovery platform. VeriStrat, a multivariate serum protein test, is Biodesix’s first product developed with this technology. The commercially available test provides oncologists with information to help them select between erlotinib and single-agent chemotherapy for advanced lung cancer patients. Tests are processed in Biodesix’s CLIA-certified laboratory and results are reported in less than 72 hours. In addition to developing novel diagnostics independently, the company also partners with biotechnology and pharmaceutical companies to develop companion diagnostics to improve the utility of therapeutic agents.

Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies®, a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious human diseases, including inflammation, haematology, oncology and pulmonary disease. Today, the Company has approximately 25 projects in the pipeline and five Nanobodies in clinical development.

NX Prenatal is a private molecular diagnostics company developing diagnostic assays for adverse pregnancy conditions such as preterm birth. It employs the proprietary NeXosome platform, which enables advanced isolation and enrichment of exosome and microvesicle particles from bodily fluids for non-invasive biomarker evaluation.

Board of Trustees of Michigan State University, part of Michigan State University, is an American company that trusts Except Educational Religious.

Hill Top Research Corp. provides clinical research services. The firm offers safety testing, OTC products, personal cleansing, baby care, moisturization, anti aging and odor services. It serves to the personal healthcare industries. The company was founded in 1947 and is headquartered in St. Petersburg, FL.

Oxford has an introduction of an e-commerce business and also the launch and development of brand licensing programs for both the belted and shield trademarks. Oxford is a subsidiary company, wholly owned by the university of oxford. They are responsible for registration, protection, and management of the university's brand, and they use this to license the use of the brand, in a wide variety of commercial categories, globally.

Kyndryl is an IT transformation services company. They offer network services, business resilience, and hybrid cloud solutions. Their services include applications, core enterprise and zcloud, the digital workplace, security and resiliency, cloud, data, and AI, network, and edge. They committed to the health and continuous improvement of the vital systems at the heart of the digital economy.

Liberty Mutual Insurance Co. provides auto, home and life insurance services. The firm offers insurance for personal automobile, workers compensation, homeowners, commercial multiple peril, commercial automobile, general liability, global specialty, group disability, assumed reinsurance, fire and surety. The company was founded on July 1, 1912 and is headquartered in Boston, MA.

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

Toray Advanced Film manufactures, processes, and sells resin films and sheets. Packaging films, electronics, optical, and decorative films are among the products the company offers. They provide a total of film products that make full use of film technology and film processed products that make full use of various processing technologies.

BioMarker Strategies LLC develops medicines for cancer. It provides cancer diagnostics system for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. The company was founded by Scott Allocco, Kathleen Murphy and Douglas P. Clark in May 2006 and is headquartered in Rockville, MD.